Preclose Percutaneous Endurant™ Endografting with the Proglide™ Device: a Safe and Feasible Combination

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Medical Devices

Background:

• Endovascular repair of abdominal aortic aneurysms has advanced significantly.
• Percutaneous approaches minimize surgical exposure of vascular access sites.
• The study focuses on the Perclose Proglide preclose technique for Endurant endografting.

Purpose of the Study:

• To analyze the feasibility and efficacy of the Perclose Proglide preclose technique.
• To evaluate its use in percutaneous endovascular aortic aneurysm repair (PEVAR) with Endurant endografts.
• To assess outcomes for asymptomatic infrarenal aortic aneurysms in an elective setting.

Main Methods:

• 45 patients with asymptomatic infrarenal aortic aneurysms underwent PEVAR.
• Perclose Proglide devices were used in a "preclose" technique for access site closure.
• Data collected prospectively included demographics, procedural details, and complications over a one-month follow-up.

Main Results:

• 85 access sites were closed using 170 Proglide devices, achieving 96.5% adequate hemostasis.
• Conversion to femoral cutdown occurred in 2.4% of cases.
• Mean hospitalization was 2.6 days, with 86.7% discharged within 2 days; access-related complications were 2.2%.

Conclusions:

• PEVAR with Perclose Proglide preclosing for Endurant endografting is feasible and effective for asymptomatic infrarenal aortic aneurysms.
• The percutaneous approach enables procedures under local anesthesia.
• This method offers a low risk of access-related complications and a short hospitalization period.